Showing results (11-20 of 512) with videos related to
Sort By:
Pageof 52
Journal of Neurology|May 24, 2022
Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinionMassimo Filippi, Maria Pia Amato, Diego Centonze, et al.Plos One|October 19, 2013
Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS studyFrancesco Patti, Vincenzo Brescia Morra, Maria Pia Amato, et al.Expert Review of Neurotherapeutics|August 26, 2011
Is there a future for donepezil therapy in the treatment of multiple sclerosis-related cognitive impairment?Maria Pia Amato, Emilio PortaccioExpert Review of Neurotherapeutics|October 9, 2009
Cognitive dysfunction in multiple sclerosis: current approaches to clinical managementMaria Pia Amato, Valentina ZipoliCNS Drugs|March 17, 2015
Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugsMaria Pia Amato, Emilio PortaccioJournal of the Neurological Sciences|March 23, 2007
Clinical outcome measures in multiple sclerosisMaria Pia Amato, Emilio PortaccioMultiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2026
Cognitive impairment in multiple sclerosis: Where do we stand today?Maria Pia Amato, Emilio PortaccioCNS Drugs|June 2, 2009
Improving compliance with interferon-beta therapy in patients with multiple sclerosisEmilio Portaccio, Maria Pia AmatoExpert Opinion on Pharmacotherapy|January 7, 2012
Management options in multiple sclerosis-associated fatigueMaria Pia Amato, Emilio PortaccioMultiple Sclerosis (Houndmills, Basingstoke, England)|February 23, 2019
Breastfeeding and post-partum relapses in multiple sclerosis patientsEmilio Portaccio, Maria Pia AmatoPageof 52